Literature DB >> 2426704

Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.

A Harel-Bellan, A Quillet, C Marchiol, R DeMars, T Tursz, D Fradelizi.   

Abstract

Natural killer (NK) cells exist in each individual in the absence of any intentional immunization. They are able to kill a wide range of targets from tumoral as well as from normal origin. However, their exact physiologic role is not clearly understood. In this study we report results about a human Epstein-Barr virus-transformed B-cell line from which variants perturbed in the expression of HLA molecules have been derived. Our results indicate that in these cell lines an inverse relationship exists between expression of HLA antigens and susceptibility to NK lysis. The original cell line is highly resistant to NK lysis. On the contrary, the variant perturbed in class I antigen expression is highly susceptible. Variant perturbed in class II antigen expression is intermediate in susceptibility. Interferon, which induces HLA class I expression and NK resistance in the unrelated classical K-562 target cells, does not change either HLA expression or NK susceptibility in the variant cell lines. The difference between the original cell line and the variants does not reside in the ability to be bound by NK effectors. Our results suggest a different role for HLA molecules. By some unknown mechanism discussed here, the presence of HLA molecules at the surface of a cell would prevent this cell from being killed by NK cells. The loss of this "good health" signal would lead to the elimination of the cell through NK lysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426704      PMCID: PMC386354          DOI: 10.1073/pnas.83.15.5688

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells.

Authors:  M E Nunn; R B Herberman; H T Holden
Journal:  Int J Cancer       Date:  1977-09-15       Impact factor: 7.396

2.  Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.

Authors:  R DeMars; R Rudersdorf; C Chang; J Petersen; J Strandtmann; N Korn; B Sidwell; H T Orr
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 3.  Natural killer cells.

Authors:  J C Roder; K Karre; R Kiessling
Journal:  Prog Allergy       Date:  1981

Review 4.  Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens.

Authors:  R DeMars; C C Chang; S Shaw; P J Reitnauer; P M Sondel
Journal:  Hum Immunol       Date:  1984-10       Impact factor: 2.850

5.  Receptor for transferrin may be a "target" structure for natural killer cells.

Authors:  L Vodinelich; R Sutherland; C Schneider; R Newman; M Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

6.  Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.

Authors:  R DeMars; C C Chang; R A Rudersdorf
Journal:  Hum Immunol       Date:  1983-10       Impact factor: 2.850

7.  Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line.

Authors:  R DeMars; C C Chang; M Marrari; R J Duquesnoy; H Noreen; M Segall; F H Bach
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

8.  Natural killer cells kill tumour cells at a given stage of differentiation.

Authors:  M Gidlund; A Orn; P K Pattengale; M Jansson; H Wigzell; K Nilsson
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

9.  A minimum of four human class II alpha-chain genes are encoded in the HLA region of chromosome 6.

Authors:  C Auffray; J Kuo; R DeMars; J L Strominger
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

10.  HLA class-I and class-II antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferon.

Authors:  D Garson; M C Dokhélar; H Wakasugi; Z Mishal; T Tursz
Journal:  Exp Hematol       Date:  1985-10       Impact factor: 3.084

View more
  36 in total

Review 1.  Histocompatibility antigens and natural killer susceptibility.

Authors:  J Peña; R Solana
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.

Authors:  W J Storkus; R D Salter; J Alexander; F E Ward; R E Ruiz; P Cresswell; J R Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.

Authors:  W J Storkus; J Alexander; J A Payne; J R Dawson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 4.  Can we make a better match or mismatch with KIR genotyping?

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

6.  Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.

Authors:  Y Z Jiang; D Couriel; D A Mavroudis; P Lewalle; V Malkovska; N F Hensel; S Dermime; J Molldrem; A J Barrett
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

7.  MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.

Authors:  R A Jones; C S Scott; F E Katz; J A Child
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells.

Authors:  P I Lobo; H C Patel
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

9.  Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.

Authors:  M Maio; M Altomonte; R Tatake; R A Zeff; S Ferrone
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

10.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.